Institutional investors purchased a net $770.8 thousand shares of GHDX during the quarter ended September 2016 and now own 91.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAKER BROS. ADVISORS LP Bought 275.3 Thousand shares of Genomic Health Inc
GOLDMAN SACHS ASSET MANAGEMENT I... Bought 15.0 Thousand shares of Genomic Health Inc
CANDRIAM BELGIUM SA Bought 8.0 Thousand shares of Genomic Health Inc